Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.

Stocks | Futures | Watchlist | More
or

Endra Life Sciences Inc (NDRA)

Endra Life Sciences Inc (NDRA)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 91,264
  • Shares Outstanding, K 41,673
  • Annual Sales, $ 0 K
  • Annual Income, $ -11,730 K
  • 60-Month Beta 1.22
  • Price/Sales N/A
  • Price/Cash Flow N/A
  • Price/Book 4.99
Trade NDRA with:

Analyst Rating / Earnings Estimates

Current Rating
See More
Strong Buy
Based on 1 analysts offering recommendations.
Earnings Estimates - Current Qtr 06/30/21
See More
  • Average Estimate -0.07
  • Number of Estimates 1
  • High Estimate -0.07
  • Low Estimate -0.07
  • Prior Year -0.20
  • Growth Rate Est. (year over year) +65.00%

Price Performance

See More
Period Period Low Period High Performance
1-Month
1.98 +6.57%
on 06/03/21
2.44 -13.52%
on 06/11/21
-0.06 (-2.76%)
since 05/18/21
3-Month
1.92 +9.90%
on 05/11/21
2.93 -27.99%
on 03/19/21
-0.63 (-22.99%)
since 03/18/21
52-Week
0.65 +224.12%
on 10/02/20
3.10 -31.94%
on 03/18/21
+1.06 (+100.95%)
since 06/18/20

Most Recent Stories

More News
ENDRA Life Sciences Appoints Irina Pestrikova as Senior Director of Finance, Announces Departure of CFO David Wells

ANN ARBOR, MI / ACCESSWIRE / June 15, 2021 / (NASDAQ:NDRA), a pioneer of Thermo Acoustic Enhanced UltraSound (TAEUS®), announced the appointment of Irina Pestrikova as Senior Director of Finance and...

NDRA : 2.11 (-3.65%)
ENDRA Life Sciences Set to Join the Russell Microcap(R) Index

ANN ARBOR, MI / ACCESSWIRE / June 9, 2021 / (NASDAQ:NDRA), a pioneer of Thermo Acoustic Enhanced UltraSound (TAEUS®), announces that it is expected to be added to the Russell Microcap® Index according...

NDRA : 2.11 (-3.65%)
ENDRA Life Sciences Reports First Quarter 2021 Financial Results and Provides Business Update

NDRA : 2.11 (-3.65%)
ENDRA Life Sciences to Report First Quarter 2021 Financial Results on May 17, 2021

ANN ARBOR, MI / ACCESSWIRE / May 6, 2021 / (ENDRA) (NASDAQ:NDRA), a pioneer of enhanced ultrasound technologies, today announced that the company will report financial results for the first quarter of...

NDRA : 2.11 (-3.65%)
Thinking about buying stock in Chiasma, Athenex, iBio, BioLineRx, or Endra Life Sciences?

, /PRNewswire/ -- InvestorsObserver issues critical PriceWatch Alerts for CHMA, ATNX, IBIO, BLRX, and NDRA.

IBIO : 1.5300 (-0.65%)
ATNX : 4.70 (-3.09%)
CHMA : 4.21 (+1.94%)
BLRX : 2.74 (+1.48%)
NDRA : 2.11 (-3.65%)
ENDRA Life Sciences Further Strengthens TAEUS(R) System's Intellectual Property Protection with Issuance of Two U.S. Patents

ANN ARBOR, MI / ACCESSWIRE / May 4, 2021 / (NASDAQ:NDRA), a pioneer of Thermo Acoustic Enhanced UltraSound (TAEUS®), announces the Company has recently been issued U.S. Patent 10993624 (the '624 patent)...

NDRA : 2.11 (-3.65%)
Thinking about buying stock in Atossa Therapeutics, AMC Entertainment, T2 Biosystems, AcelRx Pharmaceuticals, or ENDRA Life Sciences?

, /PRNewswire/ -- InvestorsObserver issues critical PriceWatch Alerts for ATOS, AMC, TTOO, ACRX, and NDRA.

AC : 37.15 (-0.59%)
ACRX : 1.3900 (-1.42%)
TTOO : 1.2900 (-0.77%)
ATOS : 5.35 (+4.09%)
NDRA : 2.11 (-3.65%)
AMC : 59.26 (-2.42%)
Zacks Industry Outlook Highlights: MedTech, including Natus Medical, Owens & Minor, Penumbra, Apollo Medical and ENDRA Life Sciences

Zacks Industry Outlook Highlights: MedTech, including Natus Medical, Owens & Minor, Penumbra, Apollo Medical and ENDRA Life Sciences

OMI : 43.70 (-1.84%)
PEN : 267.57 (-2.08%)
NDRA : 2.11 (-3.65%)
AMEH : 53.47 (-3.08%)
NTUS : 28.54 (-0.80%)
5 MedTech Outperformers With Nearly 40% or More Gain in 2021

Here are a few MedTech stocks, Natus Medical (NTUS), Owens & Minor (OMI), ENDRA Life Sciences (NDRA), Penumbra (PEN), Apollo Medical (AMEH), which might be prudent investment choices now.

OMI : 43.70 (-1.84%)
ABT : 110.33 (-1.16%)
HSIC : 75.02 (-2.18%)
PEN : 267.57 (-2.08%)
NDRA : 2.11 (-3.65%)
AMEH : 53.47 (-3.08%)
NTUS : 28.54 (-0.80%)
Clinical Trials Critical for the Evaluation of Advanced Medical Imaging Tools

, /PRNewswire/ -- Image-guided surgery offers surgeons greater control of the procedure and real-time feedback, thus providing better outcomes for patients. Accuracy in surgical procedures is critical...

BFLY : 13.95 (+0.22%)
NDRA : 2.11 (-3.65%)
ASXC : 3.20 (-4.48%)
AVGR : 1.1000 (-3.51%)
PINK.VN : 3.150 (-1.56%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 8% Buy with a Weakening short term outlook on maintaining the current direction.

See More Share

Business Summary

ENDRA Life Sciences Inc. is a developer of enhanced ultrasound technologies. ENDRA Life Sciences Inc. is based in Ann Arbor, United States.

See More

Key Turning Points

3rd Resistance Point 2.30
2nd Resistance Point 2.25
1st Resistance Point 2.18
Last Price 2.11
1st Support Level 2.06
2nd Support Level 2.01
3rd Support Level 1.94

See More

52-Week High 3.10
Fibonacci 61.8% 2.16
Last Price 2.11
Fibonacci 50% 1.88
Fibonacci 38.2% 1.59
52-Week Low 0.65

See More

Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.
Get Streaming Chart Updates
Switch your Site Preferences
to Interactive Chart
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar